Related Experiment Videos
[Iron overload and insulin resistance].
M-C Vantyghem1, C Girardot, A Boulogne
1Service d'endocrinologie et métabolisme, CHU, Lille. mc-vantyghem@chru-lille.fr
Presse Medicale (Paris, France : 1983)
|November 18, 2005
Summary
Moderately elevated body iron stores, even without genetic hemochromatosis, are linked to adverse health outcomes. High serum ferritin, a marker of iron status, predicts type 2 diabetes and metabolic syndrome.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Health
Background:
- Genetic hemochromatosis involves high transferrin saturation (TS) and HFE C282Y homozygosity.
- Other genes and environmental factors influence iron overload phenotypes.
- Dysmetabolic hepatosiderosis presents with high serum ferritin and normal TS.
Purpose of the Study:
- To explore the association between moderately elevated body iron stores and adverse health outcomes.
- To differentiate iron overload without hemochromatosis from genetic hemochromatosis.
- To investigate the predictive value of serum ferritin in metabolic diseases.
Main Methods:
- Review of evidence linking body iron stores to health outcomes.
- Analysis of genetic and environmental modulators of iron overload.
- Examination of prospective studies on serum ferritin and disease incidence.
Main Results:
- Elevated serum ferritin predicts incident type 2 diabetes.
- High ferritin levels are associated with hypertension, dyslipidemia, and metabolic syndrome.
- Serum ferritin can be a marker of insulin resistance, not always indicating iron overload.
Conclusions:
- Moderately elevated iron stores pose health risks independent of genetic hemochromatosis.
- Serum ferritin is a significant predictor of metabolic disturbances.
- Further research is needed to clarify the role of ferritin in insulin resistance.